One Biosciences Expands to Albany, New York
One Biosciences, a prominent French biotech company, is establishing its first U.S. location at the Life Sciences Innovation Building on the Albany College of Pharmacy and Health Sciences campus. This significant move marks the company’s expansion beyond France, aided by support from Empire State Development, New York’s economic development agency.
Strategic Location Choice
Located on New Scotland Avenue, the Life Sciences Innovation Building, formerly known as the Center for Medical Sciences, will host One Biosciences’ new operations. The firm intends to leverage the resources and collaborative environment of this academic institution to enhance its research and development efforts in personalized cancer treatments.
Economic Incentives and Commitments
New York State is offering One Biosciences $525,000 in tax credits through the Excelsior Jobs Program, which incentivizes job creation. In return, the company has committed to creating 42 new jobs and investing $18 million in its Albany facility over the next five years. This partnership reflects the state’s ongoing efforts to attract and nurture innovative biotech firms.
Historical Roots and Research Focus
One Biosciences emerged from the prestigious Institut Curie in Paris, a leading cancer research facility founded by the Nobel laureate Marie Curie in 1909. The institute has a storied history of groundbreaking research in radiation and cancer studies, setting the stage for One Biosciences’ commitment to harnessing artificial intelligence to advance personalized medicine.
State Commitment to Life Sciences
Governor Kathy Hochul emphasized the importance of life sciences in New York’s economy, stating that the state’s initiatives aim to foster the growth of cutting-edge companies like One Biosciences. With a dedicated $620 million program for attracting biotech firms, New York is positioning itself as a hub for medical innovation and breakthroughs.
A Thriving Biotech Ecosystem
The Capital Region is becoming increasingly significant in the life sciences sector, with major players like Regeneron and GE Healthcare contributing to local employment and economic vitality. The Albany College of Pharmacy and Health Sciences also plays a crucial role in nurturing biotech startups through its Stack Family Center for Biopharmaceutical Education and Training.
Collaborative Research Environment
One Biosciences is already on the ground in Albany, although the full move into its new facility is pending completion of renovations. The presence of other biotech entities, such as the Neural Stem Cell Institute and Bella Biologics, within the same building fosters a collaborative atmosphere ideal for innovation, research, and development.
Future Prospects and Mergers
The Albany College of Pharmacy and Health Sciences is set to merge with Russell Sage College in 2027, further enhancing the region’s status as a center for health professions and sciences. This development is expected to benefit the broader life sciences community without adversely affecting the One Biosciences operations.
Advancements in Cancer Treatment
One Biosciences aims to revolutionize cancer treatment by developing technologies that allow for a deeper understanding of individual patient profiles. This focus on personalized therapies aligns with the growing trend of tailoring medical treatments to specific genetic profiles, thereby improving outcomes for patients worldwide.
Conclusion
The establishment of One Biosciences in Albany is a promising development for both the company and the local biotech landscape. This initiative not only showcases New York’s commitment to fostering innovation but also highlights the potential for significant advancements in personalized medicine. As One Biosciences integrates into the community, it is poised to contribute meaningfully to the future of cancer treatment and research.
- Key Takeaways:
- One Biosciences opens its first U.S. location in Albany, NY.
- The company is committed to creating 42 jobs and investing $18 million.
- It emerged from the renowned Institut Curie in Paris.
- New York State aims to strengthen its biotech sector with significant economic incentives.
- Albany’s life sciences ecosystem supports collaboration among biotech firms.
Read more → www.timesunion.com